Your browser is no longer supported. Please, upgrade your browser.
FMI Foundation Medicine, Inc. daily Stock Chart
FMI [NASD]
Foundation Medicine, Inc.
Index- P/E- EPS (ttm)-4.21 Insider Own2.10% Shs Outstand37.04M Perf Week0.18%
Market Cap5.07B Forward P/E- EPS next Y-3.00 Insider Trans-27.01% Shs Float15.28M Perf Month0.37%
Income-152.40M PEG- EPS next Q-1.05 Inst Own36.30% Short Float15.37% Perf Quarter88.12%
Sales179.40M P/S28.28 EPS this Y-38.30% Inst Trans0.25% Short Ratio4.08 Perf Half Y103.64%
Book/sh0.51 P/B268.53 EPS next Y28.40% ROA-94.80% Target Price92.50 Perf Year260.39%
Cash/sh- P/C- EPS next 5Y- ROE-299.60% 52W Range31.70 - 137.20 Perf YTD100.81%
Dividend- P/FCF- EPS past 5Y15.50% ROI-175.50% 52W High-0.18% Beta-0.08
Dividend %- Quick Ratio2.00 Sales past 5Y70.40% Gross Margin47.30% 52W Low332.02% ATR1.51
Employees682 Current Ratio2.30 Sales Q/Q100.80% Oper. Margin-84.00% RSI (14)81.51 Volatility0.10% 0.12%
OptionableYes Debt/Eq4.76 EPS Q/Q22.40% Profit Margin-85.00% Rel Volume1.55 Prev Close136.90
ShortableYes LT Debt/Eq4.76 EarningsJul 31 AMC Payout- Avg Volume575.87K Price136.95
Recom2.80 SMA200.20% SMA5022.51% SMA20078.80% Volume894,530 Change0.04%
Jan-29-18Initiated Goldman Neutral $73
Sep-16-15Downgrade Wells Fargo Outperform → Market Perform
Jul-30-15Downgrade JMP Securities Mkt Outperform → Mkt Perform
Mar-10-15Initiated UBS Neutral $50
Aug-01-14Initiated Tigress Financial Neutral
Jul-18-18 04:00PM  Foundation Medicine and Guardant Health Agree to Settle Patent Infringement Lawsuit Business Wire
Jul-05-18 08:47AM  3 Best Biotech Acquisitions of 2018 (So Far) Motley Fool
Jul-02-18 11:36AM  Roche commences tender offer for all shares of Foundation Medicine, Inc. for US$ 137.00 per share in cash GlobeNewswire
Jun-25-18 01:29PM  What Roche's Acquisition of Foundation Medicine Means for Investors Motley Fool
Jun-22-18 09:52AM  Pharma Stock Roundup: PTCT Unveils Promising Data, RHHBY to Acquire Rest of FMI Zacks
09:20AM  Big Biotech Stock Pops and Drops This Week Motley Fool
07:30AM  [$$] Gormley's Take: Precision-Medicine Drive Gathers Momentum The Wall Street Journal
Jun-20-18 01:20PM  FOUNDATION MEDICINE, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout Business Wire
10:00AM  Company News For Jun 20, 2018 Zacks
08:00AM  Todays Research Reports on Stocks to Watch: Foundation Medicine and Solid Biosciences ACCESSWIRE
03:51AM  Roche to Buy Rest of Foundation Medicine for $2.4 billion Zacks
12:15AM  [$$] Jefferies great leap forward on Wall Street Financial Times
Jun-19-18 07:42PM  [$$] Roche to Pay $2.4 Billion for Full Control of Foundation Medicine The Wall Street Journal +28.46%
06:18PM  WeissLaw LLP: Foundation Medicine, Inc. Acquisition May Not Be In The Best Interest of FMI Shareholders PR Newswire
04:31PM  Why CVS Health, Foundation Medicine, and Solid Biosciences Jumped Today Motley Fool
04:30PM  How A Merger Will Help These Two Firms Tailor Cancer Treatments Investor's Business Daily
12:48PM  Roche Does Pharma M&A Without the Pharma Bloomberg
12:39PM  Why Foundation Medicine Stock Is Skyrocketing 28.3% Higher Today Motley Fool
10:54AM  Netflix expands, Amazon teams up with Marriott, Wells Fargo merging wealth management groups Yahoo Finance
10:48AM  Mattel, Foundation Medicine and Sirius are the Yahoo Finance Charts of the day. Yahoo Finance Video
10:21AM  Netflix expands and has price target raised, Amazon teams up with Marriott hotels, Wells Fargo merging wealth management groups Yahoo Finance Video
08:58AM  Stocks fall deep into the red as trade war escalates Yahoo Finance
08:37AM  [$$] Roche to Pay $2.4 Billion for Full Control of Foundation Medicine The Wall Street Journal
04:57AM  [$$] European Corporate Roundup for Tuesday The Wall Street Journal
04:35AM  Roche pays $2.4 billion for rest of cancer expert Foundation Medicine Reuters
03:57AM  [$$] Roche to Buy Rest of Foundation Medicine The Wall Street Journal
03:36AM  Roche pays $2.4 billion for rest of cancer expert Foundation Medicine Reuters
01:01AM  Roche and Foundation Medicine reach definitive merger agreement to accelerate broad availability of comprehensive genomic profiling in oncology GlobeNewswire
12:09AM  [$$] Roche to spend $2.4bn buying rest of Foundation Medicine Financial Times
Jun-18-18 11:54PM  [$$] Genomics/Roche: precision vision Financial Times
Jun-05-18 07:00AM  Foundation Medicine to Present at Upcoming Investor Conferences Business Wire
May-31-18 11:10AM  5 Top Performing Stocks of the Best ETF of May Zacks
May-29-18 07:00AM  Foundation Medicine and Collaborators to Present New Data at ASCO 2018 Supporting Comprehensive Genomic Profiling (CGP) to Inform Personalized Approaches in Cancer Care Business Wire
May-25-18 06:31PM  3 Stocks That Look Just Like eBay in 1998 Motley Fool
May-24-18 07:00AM  Foundation Medicine Establishes Immuno-Oncology Companion Diagnostics Collaboration with Merck Business Wire
May-22-18 08:10AM  Today's Research Reports on Trending Tickers: Celgene and Foundation Medicine ACCESSWIRE
08:10AM  Analysis: Positioning to Benefit within Front Yard Residential, Foundation Medicine, SPX FLOW, Silicon Laboratories, John Wiley & Sons, and Hub Group Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
May-21-18 07:00AM  Foundation Medicine Receives New ADLT Status for FoundationOne CDx from the Centers for Medicare and Medicaid Services (CMS) Business Wire +7.27%
May-11-18 08:16AM  3 Healthcare Stocks Growing Over 100% Motley Fool
May-03-18 11:55PM  Edited Transcript of FMI earnings conference call or presentation 2-May-18 8:30pm GMT Thomson Reuters StreetEvents
May-02-18 05:36PM  Foundation Medicine: 1Q Earnings Snapshot Associated Press
04:01PM  Foundation Medicine Announces 2018 First Quarter Results and Recent Highlights Business Wire
07:00AM  Foundation Medicine Launches Gene Expression Profiling Program to Identify Known and Novel Biomarkers in Advanced Cancer Business Wire
Apr-26-18 09:35PM  BRIEF-Dian Diagnostics In Separate Agreements With Foundation Medicine, F. Hoffmann-La Roche Reuters
06:00PM  Foundation Medicine, Roche and DIAN Diagnostics Collaborate to Advance Personalized Cancer Care in China Business Wire
07:00AM  Foundation Medicines New Liquid Biopsy Assay Granted Breakthrough Device Designation by U.S. Food and Drug Administration Business Wire
Apr-18-18 07:45AM  How BTCY Could Look a Lot Like SRPT in a Year's Time ACCESSWIRE
Apr-17-18 07:00AM  Foundation Medicine Announces Timing for First Quarter 2018 Financial Results and Conference Call Business Wire +8.89%
Apr-11-18 07:00AM  Foundation Medicine and its Collaborators Present New Findings Supporting Tissue- and Blood-based Comprehensive Genomic Profiling (CGP) to Inform Targeted and Cancer Immunotherapy Treatment Strategies Business Wire
Apr-09-18 08:54AM  Cancer Treatment Centers of America and Foundation Medicine Launch Joint Educational Campaign to Raise Consumer Awareness of Precision Medicine Approaches in Cancer Care PR Newswire +5.17%
Apr-04-18 11:19AM  Does Foundation Medicine Incs (NASDAQ:FMI) Debt Level Pose A Problem? Simply Wall St. +5.86%
Mar-30-18 07:00AM  Foundation Medicine Announces Commercial Availability of FoundationOne CDx, the First FDA-Approved Comprehensive Genomic Profiling Assay for All Solid Tumors Incorporating Multiple Companion Diagnostics Business Wire
Mar-29-18 07:30AM  Research Report Identifies Beazer Homes, Extra Space Storage, Foundation Medicine, Kennametal, Midstates Petroleum, and Corporate Office Properties Trust with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Mar-23-18 12:48PM  Foundation Medicine Inc (NASDAQ:FMI): Will The Growth Last? Simply Wall St.
Mar-20-18 07:00AM  Blog Exposure - Foundation Medicine Collaborated with Chugai for Commercialization of FoundationOne CDx(TM) in Japan ACCESSWIRE
Mar-18-18 10:19PM  Foundation Medicine Announces Final National Coverage Determination (NCD) from the Centers for Medicare & Medicaid Services (CMS), Including Coverage for FoundationOne CDx Across All Solid Tumors Business Wire
Mar-16-18 06:45PM  Medicare Will Cover Genetic Cancer Testing, With Caveats Forbes
02:00AM  Foundation Medicine Advances Patient Access to Precision Medicine; Pursues Regulatory Approval for FoundationOne CDx in Japan Business Wire
01:16AM  Edited Transcript of FMI earnings conference call or presentation 7-Mar-18 9:30pm GMT Thomson Reuters StreetEvents
Mar-13-18 04:05PM  Foundation Medicine and Guardant Health Agree to Resolve False Advertising Lawsuit Business Wire
Mar-08-18 07:04PM  Foundation Medicine (FMI) Q4 2017 Earnings Conference Call Transcript Motley Fool
06:30AM  Foundation Medicine to Present at Cowen and Companys 38th Annual Healthcare Conference Business Wire
Mar-07-18 04:35PM  Foundation Medicine reports 4Q loss Associated Press
04:01PM  Foundation Medicine Announces 2017 Fourth Quarter and Year-End Results, Recent Highlights and 2018 Outlook Business Wire
12:30PM  Foundation Medicine, Inc. to Host Earnings Call ACCESSWIRE
Feb-21-18 06:30AM  3 Growth Stocks That Could Put Netflix's Returns to Shame Motley Fool
Feb-19-18 04:31PM  Does Foundation Medicine Incs (NASDAQ:FMI) Past Performance Indicate A Weaker Future? Simply Wall St.
Feb-15-18 04:56PM  Foundation Medicine Set For 'Material Upside,' Cowen Says In Bullish Initiation Benzinga +5.11%
Feb-13-18 06:30AM  Foundation Medicine Announces Timing for Fourth Quarter and Year-End 2017 Financial Results and Conference Call Business Wire
Feb-05-18 01:04PM  3 Things to Really Like About Bristol-Myers Squibb's Q4 Earnings Results Motley Fool
Jan-30-18 07:00AM  Foundation Medicine and European Organisation for Research and Treatment of Cancer (EORTC) Announce Collaboration to Advance Precision Medicine Using Comprehensive Genomic Profiling to Facilitate Clinical Trial Enrollment Business Wire
Jan-26-18 07:35AM  Report: Exploring Fundamental Drivers Behind Lands' End, Foundation Medicine, Benefitfocus, Corporate Office Properties Trust, Forest City Realty Trust, and United Dominion Realty Trust New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Jan-23-18 01:35PM  Forget Bitcoin, You're Better Off Buying These 3 Stocks Motley Fool
Jan-16-18 07:00AM  Foundation Medicine and Pfizer Announce Broad Partnership to Develop Companion Diagnostics for Pfizers Oncology Portfolio Business Wire
Jan-08-18 06:30AM  Foundation Medicine Reports Preliminary 2017 Results Business Wire
Jan-03-18 04:01PM  Foundation Medicine to Present at the 36th Annual J.P. Morgan Healthcare Conference Business Wire
12:18PM  What does Foundation Medicine Incs (NASDAQ:FMI) Balance Sheet Tell Us Abouts Its Future? Simply Wall St.
Dec-14-17 01:23PM  ETFs with exposure to Foundation Medicine, Inc. : December 14, 2017 Capital Cube
Dec-11-17 12:50PM  Foundation Medicine CEO talks the future of cancer treatm... CNBC Videos
Dec-06-17 07:00AM  Foundation Medicine and Collaborators to Present New Data at the American Society of Hematology (ASH) Annual Meeting that Supports Use of FoundationOne®Heme to Advance Personalized Medicine in Blood Cancers Business Wire
Dec-05-17 10:15AM  Company News For Dec 5, 2017 Zacks -5.38%
Dec-04-17 08:09PM  [$$] Ex-Google Ventures Chief Bill Maris Hires Partner for Venture Firm The Wall Street Journal
06:00AM  Ex-Googler Maris Adds Partner From Foundation Medicine Bloomberg
01:40AM  Roche's Foundation Medicine wins FDA blessing for new cancer test Reuters
01:33AM  Roche's Foundation Medicine wins FDA blessing for new cancer test Reuters
Dec-02-17 10:30AM  The FDA Ushers In a New Era in Cancer Treatment Motley Fool
Dec-01-17 05:23PM  Charting the Market: Foundation Medicine's Test Flags 324 Cancer Genes Barrons.com +17.67%
04:33PM  This Biotech Launched To A Record High On Cancer Test Approval Investor's Business Daily
04:30PM  Why Ambarella, Foundation Medicine, and Mylan Jumped Today Motley Fool
04:16AM  FDA Approves Foundation Medicine's FoundationOne CDx Diagnostic Test for Solid Tumors Benzinga
Nov-30-17 11:15PM  FDA Approves Foundation Medicines FoundationOne CDx, the First and Only Comprehensive Genomic Profiling Test for All Solid Tumors Incorporating Multiple Companion Diagnostics Business Wire +5.24%
06:34PM  Foundation's cancer gene test gets U.S. FDA and Medicare nod Reuters
05:00PM  Foundation Medicine gets nod from FDA and Medicare for cancer test Reuters
Nov-29-17 11:35AM  ETFs with exposure to Foundation Medicine, Inc. : November 29, 2017 Capital Cube
Nov-17-17 11:55AM  ETFs with exposure to Foundation Medicine, Inc. : November 17, 2017 Capital Cube
Nov-07-17 08:33AM  Options Traders Expect Huge Moves in Foundation Medicine (FMI) Stock Zacks -6.62%
Nov-06-17 11:35AM  ETFs with exposure to Foundation Medicine, Inc. : November 6, 2017 Capital Cube
Nov-03-17 10:08AM  Foundation Medicine, Inc. :FMI-US: Earnings Analysis: Q3, 2017 By the Numbers : November 3, 2017 Capital Cube
03:41AM  Edited Transcript of FMI earnings conference call or presentation 1-Nov-17 8:30pm GMT Thomson Reuters StreetEvents
Nov-02-17 09:00PM  The Precision Medicine Stock That's Revolutionizing Cancer Treatment Motley Fool +19.50%
Foundation Medicine, Inc. provides various molecular information products in the United States. The company's molecular information platform includes proprietary methods and algorithms to analyze specimens across various types of cancer, as well as for incorporating that information into clinical care; and offers genomic insights about each patient's individual cancer, enabling physicians to optimize treatments in clinical practice and biopharmaceutical companies to develop targeted therapies and immunotherapies. It provides clinical products, such as FoundationOne for solid tumors; FoundationOne Heme for blood-based cancers, or hematologic malignancies, including leukemia, lymphoma, and sarcomas; Foundation Assay for Circulating Tumor; FoundationFocus CDxBRCA, a diagnostic assay to aid in identifying women with ovarian cancer; and FoundationOne CDx, a diagnostic assay for solid tumors. The company also offers FoundationCORE, a knowledgebase to publish scientific and medical advances, and foster relationships throughout the oncology community. In addition, it has strategic collaboration agreements with F. Hoffmann-La Roche Ltd.; and Genentech, Inc. Foundation Medicine, Inc. has a collaboration with The European Organisation for Research and Treatment of Cancer to advance precision medicine using comprehensive genomic profiling to facilitate clinical trial enrollment. It also has a three-party collaboration agreement with F. Hoffmann-La Roche Ltd and DIAN Diagnostics Group, Co., Ltd. to integrate the company's comprehensive genomic profiling assays into clinical patient care in mainland China. The company was founded in 2009 and is headquartered in Cambridge, Massachusetts. Foundation Medicine, Inc. is a subsidiary of Roche Holdings, Inc.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Nallicheri MelanieChief Business OfficerJul 02Sale136.662,008274,41366,011Jul 05 04:09 PM
Ryan JasonChief Financial OfficerJul 02Sale136.663,403465,05449,170Jul 05 04:10 PM
Miller Vincent A.Chief Medical OfficerJul 02Sale136.662,909397,54467,179Jul 05 04:09 PM
Doherty Michael JHead of Product DevelopmentJul 02Sale136.662,675365,56681,287Jul 05 04:07 PM
Fiedler KonstantinChief Operating OfficerJul 02Sale136.66994135,84026,835Jul 05 04:08 PM
Hesslein Robert W.SVP and General CounselJul 02Sale136.662,520344,383105,203Jul 05 04:08 PM
Cox TroyChief Executive OfficerJul 02Sale136.661,402191,597242,068Jul 05 04:06 PM
Pellini Michael JDirectorJun 15Sale105.453,500369,075103,711Jun 19 04:03 PM
Miller Vincent A.Chief Medical OfficerMay 21Option Exercise29.941,57047,00671,658May 23 04:06 PM
Miller Vincent A.Chief Medical OfficerMay 21Sale85.001,570133,45070,088May 23 04:06 PM
Cox TroyChief Executive OfficerMay 16Sale77.102,157166,305243,470May 17 04:13 PM
Pellini Michael JDirectorMay 15Sale76.053,500266,175107,211May 17 04:12 PM
Cox TroyChief Executive OfficerMay 07Sale70.017,063494,481245,627May 09 04:04 PM
Ryan JasonChief Financial OfficerApr 16Sale74.303,449256,26152,573Apr 18 04:08 PM
Miller Vincent A.Chief Medical OfficerApr 16Sale74.023,283243,00870,088Apr 18 04:07 PM
Pellini Michael JDirectorApr 16Sale74.653,500261,275110,711Apr 18 04:08 PM
Doherty Michael JHead of Product DevelopmentApr 03Sale72.40214583,962Apr 05 04:15 PM
Ryan JasonChief Financial OfficerApr 03Sale72.4017256,022Apr 05 04:15 PM
Pellini Michael JDirectorApr 03Sale70.2813,659959,955114,211Apr 05 04:14 PM
Hesslein Robert W.SVP and General CounselApr 02Option Exercise7.122,34416,689109,308Apr 03 04:11 PM
Miller Vincent A.Chief Medical OfficerApr 02Sale74.882,883215,87173,371Apr 03 04:11 PM
Fiedler KonstantinChief Operating OfficerApr 02Sale74.8835826,80727,829Apr 03 04:10 PM
Doherty Michael JHead of Product DevelopmentApr 02Sale74.878,190613,18583,964Apr 03 04:09 PM
Nallicheri MelanieChief Business OfficerApr 02Sale74.881,25393,82568,019Apr 03 04:13 PM
Ryan JasonChief Financial OfficerApr 02Sale76.236,139467,95956,023Apr 03 04:13 PM
Hesslein Robert W.SVP and General CounselApr 02Sale74.881,585118,685107,723Apr 03 04:11 PM
Ryan JasonChief Financial OfficerMar 15Option Exercise29.6315,000444,45057,083Mar 19 04:17 PM
Pellini Michael JDirectorMar 15Sale78.293,500274,015127,870Mar 19 04:18 PM
Ryan JasonChief Financial OfficerMar 15Sale78.2615,0001,173,90049,230Mar 19 04:17 PM
Miller Vincent A.Chief Medical OfficerFeb 20Option Exercise29.946,811203,92180,133Mar 12 04:15 PM
Miller Vincent A.Chief Medical OfficerFeb 20Option Exercise6.4712,00877,703102,697Feb 22 04:03 PM
Miller Vincent A.Chief Medical OfficerFeb 20Sale76.8732,0082,460,45573,322Feb 22 04:03 PM
Miller Vincent A.Chief Medical OfficerFeb 20Sale85.0016,8111,428,93563,322Mar 12 04:15 PM
Ryan JasonChief Financial OfficerFeb 15Option Exercise29.6315,000444,45064,230Feb 20 04:05 PM
Ryan JasonChief Financial OfficerFeb 15Sale67.5315,0001,012,95049,230Feb 20 04:05 PM
Pellini Michael JDirectorFeb 15Sale67.6917,3241,172,662131,370Feb 20 04:04 PM
Cox TroyChief Executive OfficerFeb 15Sale67.229,012605,787215,333Feb 20 04:04 PM
Kafka Steven J.President & COOFeb 13Sale61.5529,7911,833,63631,570Feb 15 04:06 PM
Kafka Steven J.President & COOFeb 07Sale70.1323,0641,617,47861,361Feb 09 04:04 PM
Cox TroyChief Executive OfficerFeb 07Sale70.1326,7131,873,383224,345Feb 09 04:03 PM
Miller Vincent A.Chief Medical OfficerJan 29Option Exercise4.164,40018,30497,722Jan 31 04:03 PM
Miller Vincent A.Chief Medical OfficerJan 29Sale75.004,400330,00093,322Jan 31 04:03 PM
Miller Vincent A.Chief Medical OfficerJan 22Option Exercise0.8417,18714,437110,509Jan 24 04:19 PM
Miller Vincent A.Chief Medical OfficerJan 22Sale70.2717,1871,207,73093,322Jan 24 04:19 PM
Miller Vincent A.Chief Medical OfficerJan 17Option Exercise0.845,5344,64998,856Jan 18 04:04 PM
Pellini Michael JDirectorJan 17Sale65.5210,150665,028148,694Jan 18 04:04 PM
Miller Vincent A.Chief Medical OfficerJan 17Sale65.395,534361,86893,322Jan 18 04:04 PM
Miller Vincent A.Chief Medical OfficerJan 16Option Exercise0.845,4084,54398,730Jan 18 04:04 PM
Ryan JasonChief Financial OfficerJan 16Option Exercise29.6320,000592,60069,230Jan 18 04:05 PM
Pellini Michael JDirectorJan 16Sale64.1927,1381,741,988158,844Jan 18 04:04 PM
Ryan JasonChief Financial OfficerJan 16Sale64.3821,0351,354,23349,230Jan 18 04:05 PM
Miller Vincent A.Chief Medical OfficerJan 16Sale65.269,221601,76293,322Jan 18 04:04 PM
Hesslein Robert W.SVP and General CounselJan 16Sale64.3018,0211,158,75098,343Jan 18 04:03 PM
Kafka Steven J.President & COOJan 16Sale65.714,148272,56584,425Jan 18 04:03 PM
Kafka Steven J.President & COOJan 03Sale64.002,257144,44888,573Jan 03 05:18 PM
Nallicheri MelanieChief Business OfficerJan 02Sale64.001,49495,61657,777Jan 03 05:19 PM
Ryan JasonChief Financial OfficerJan 02Sale64.002,336149,50450,265Jan 03 05:19 PM
Kafka Steven J.President & COOJan 02Sale64.0015710,04890,830Jan 03 05:18 PM
Miller Vincent A.Chief Medical OfficerJan 02Sale64.002,349150,33697,135Jan 03 05:18 PM
Hesslein Robert W.SVP and General CounselJan 02Sale64.001,864119,296116,364Jan 03 05:18 PM
Pellini Michael JDirectorDec 13Sale61.7148,7463,008,116185,982Dec 15 04:03 PM
JONES EVAN/ FADirectorDec 13Sale62.051,40086,87017,652Dec 15 04:02 PM
Kafka Steven J.President & COODec 07Option Exercise5.3488,361471,644141,883Dec 11 04:03 PM
Kafka Steven J.President & COODec 07Sale61.6688,3615,448,33990,987Dec 11 04:03 PM
Kafka Steven J.President & COODec 06Option Exercise4.165,77424,02096,761Dec 07 04:03 PM
Pellini Michael JDirectorDec 06Sale58.1120,9471,217,230237,228Dec 07 04:04 PM
Kafka Steven J.President & COODec 06Sale58.575,774338,18390,987Dec 07 04:03 PM
JONES EVAN/ FADirectorDec 06Sale57.8860034,72819,052Dec 07 04:03 PM
Ryan JasonChief Financial OfficerDec 05Option Exercise6.1421,726133,30271,289Dec 07 04:05 PM
Ryan JasonChief Financial OfficerDec 05Sale61.2621,7261,330,93552,601Dec 07 04:05 PM
Pellini Michael JDirectorDec 05Sale61.479,053556,488258,175Dec 07 04:04 PM
Miller Vincent A.Chief Medical OfficerDec 05Sale61.1720,0001,223,40099,984Dec 07 04:04 PM
JONES EVAN/ FADirectorDec 05Sale60.945,900359,54619,652Dec 07 04:03 PM
Ryan JasonChief Financial OfficerNov 02Sale50.009,731486,55052,601Nov 06 04:02 PM
Kafka Steven J.President & COOOct 13Sale44.623,361149,96890,987Oct 16 04:10 PM
Ryan JasonChief Financial OfficerOct 12Sale45.051,15251,89862,332Oct 16 04:10 PM
Pellini Michael JDirectorOct 02Sale38.804,349168,741267,228Oct 04 04:04 PM
Ryan JasonChief Financial OfficerOct 02Sale38.803,154122,37563,484Oct 04 04:05 PM
Miller Vincent A.Chief Medical OfficerOct 02Sale38.802,944114,227119,984Oct 04 04:03 PM
Nallicheri MelanieChief Business OfficerOct 02Sale38.805,440211,07259,271Oct 04 04:04 PM
Hesslein Robert W.SVP and General CounselOct 02Sale38.802,16584,002118,228Oct 04 04:02 PM
Kafka Steven J.President & COOOct 02Sale38.803,201124,19994,348Oct 04 04:02 PM
Daly DavidChief Commercial OfficerAug 09Option Exercise22.2446,8721,042,433163,133Aug 10 04:06 PM
Pellini Michael JDirectorAug 09Sale39.5230,0001,185,600275,077Aug 10 04:06 PM
Daly DavidChief Commercial OfficerAug 09Sale39.5046,8721,851,444116,261Aug 10 04:06 PM
Yeshwant KrishnaDirectorAug 08Sale40.014,800192,0485,786Aug 10 04:07 PM
Yeshwant KrishnaDirectorAug 04Option Exercise24.2113,385324,05119,171Aug 08 04:04 PM
Yeshwant KrishnaDirectorAug 04Sale36.8518,072665,9535,786Aug 08 04:04 PM